Dr. Steven Dinsmore completed his undergraduate education at Drexel University and earned his medical degree from the Philadelphia College of Osteopathic Medicine. His postgraduate training included an internal medicine residency at the University of Medicine & Dentistry of New Jersey, School of Osteopathic Medicine (UMDNJ-SOM), and he was board certified by the AOBIM. He then completed a neurology residency at the Medical College of Pennsylvania (now Drexel University College of Medicine) and is certified by the ABPN (American Board of Psychiatry and Neurology).

Dr. Dinsmore returned to UMDNJ-SOM and was sponsored by the University as a Special Government Employee for a two-year fellowship in neuromuscular diseases at the National Institutes of Health in Bethesda, MD. He then joined the faculty of the New Jersey Institute for Successful Aging (NJISA) of UMDNJ-SOM, achieving the rank of Associate Professor. At NJISA, he cared for adults aged 55 and older, focusing on neurodegenerative disorders, including a clinic for patients with Post-Poliomyelitis syndrome (1992–1998) and neurological evaluations for the Memory Assessment Program. After 17 years, he transitioned to the U.S. FDA as a Medical Officer in the Office of Neuroscience.

Dr. Dinsmore’s clinical experience in geriatric medicine, interest in the scientific foundations of biomedicine, research at NIH, and facility with information technology enabled a seamless transition into drug development and regulatory science. At FDA he accrued a portfolio of increasingly complex IND (Investigational New Drug Application) and NDA (New Drug Application) regulatory assessments. His work integrated his clinical background in Internal Medicine and Neurology with expanded knowledge in pharmacology, statistics, and toxicology, enabling effective collaboration with multidisciplinary FDA review teams throughout the drug development life cycle. In this role, Dr. Dinsmore developed fluency in the terminology, methodology, and critical analysis central to regulatory science.